Wearable Ultrasound Probe Enables User To See, Feel, And Do

Sonivate Medical’s finger-worn ultrasound imaging probe is a ground-breaking solution that is perfectly positioned to satisfy the growing demand for point-of-care diagnostics, as well as "wearable" technology.

The global market for ultrasound devices and services is sizeable at around $7 billion spent per year worldwide on machines and accessories. An estimated 430 million scans are performed annually on 450,000 million systems, and Sonivate Medical Inc., an Oregon-based start-up company, has its finger on the pulse of this burgeoning field with the SonicEye, an ultrasound imaging probe that is actually worn on the user’s finger. According to Sonivate president and CEO David Starr, the market for ultrasound probes alone is worth around $1.4 billion annually. Starr says one of the main advantages of the SonicEye probe is that it leverages innate human hand/eye coordination to provide both fine-motor positional control and exquisite spatial awareness of fingertip location with tactile feedback. “We have taken existing ultrasound transducer [aka probe] technology and miniaturized it and put a hole in the middle so it can be worn on the finger. It has the same image quality and imaging characteristics as traditional ultrasound transducers, but by changing the form it facilitates greater ease of use and is much easier and more intuitive to learn how to use,” he says.

The probe, which received FDA clearance in 2012, supports applications in ultrasound-guided needle procedures including vascular access, needle aspiration, and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Surgical Procedures

Medicare Tricuspid Regurgitation Coverage Decision Big Win For Abbott

 

Medicare beneficiaries with tricuspid regurgitation will now have access to an innovative treatment from Abbott that offers a minimally invasive alternative to open-heart surgery.

Bivacor Rotary Heart Could Upend The Artificial Heart Market, If It Reaches Its Destination

 
• By 

Bivacor aims to be first to the US market with a permanent total artificial heart, starting with use as a bridge to transplant. CMO William Cohn says data from countries with low transplant rates could support pivotal trials and long-term use.

Ochsner Surgeon In ‘The Big Easy’ Eases Patient’s Pain With Skill And Virtual Reality

 

A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.

From Imitation To Action: Johns Hopkins Robot Autonomously Performs Key Step In Gallbladder Surgery

 
• By 

Researchers at Johns Hopkins have used a robotic system to autonomously perform a key part of gallbladder surgery without a surgeon's hand. Lead author Axel Krieger says it could take five to 10 years before an autonomous robotic system will reach human trials and expects regulatory hurdles.

More from Surgery